Cervomed Inc stock is traded at $1.46, with a volume of 1,183,371. It is up +9.77% in the last 24 hours and down -36.24% over the past month. CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Previous Close:
$1.33
Open:
$1.53
24h Volume:
1,183,371
Relative Volume:
0.70
Market Cap:
$22.09M
Revenue:
$2.09M
Net Income/Loss:
-$30.04M
P/E Ratio:
-
EPS:
-$3.27
Net Cash Flow:
-$27.57M
1W Performance:
-13.61%
1M Performance:
-36.24%
6M Performance:
-54.94%
1Y Performance:
-83.80%
1-Day Range:
$1.40$1.65
1-Week Range:
$1.33$1.90
52-Week Range:
$1.27$10.00
Cervomed Inc Stock (CRVO) Company Profile
Name
Cervomed IncSector
HealthcareIndustry
BiotechnologyPhone
(617) 744-4400Address
20 PARK PLAZA, BOSTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS